Group 1 - The stock of Danna Biological (920009) increased by 3.07% with a turnover rate of 44.61% and a trading volume of 285 million yuan, showing a volatility of 15.41% [1] - Institutional investors net bought 3.55 million yuan, while brokerage seats collectively net sold 864,000 yuan [1][2] - The stock was listed on the exchange due to its turnover rate reaching 44.61%, with the top five trading departments having a total transaction amount of 50.22 million yuan, including a net buying amount of 2.69 million yuan [2][3] Group 2 - Among the trading departments, one institutional seat was present, which net bought 3.55 million yuan [3] - The top buying departments included Dongfang Caifu Securities and Bank of China International Securities, with significant buy and sell amounts [3] - The trading data indicates a competitive buying environment, with the largest buy amount from Dongfang Caifu Securities at 5.44 million yuan and the largest sell amount also from the same department at 7.89 million yuan [3]

（记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。 每经讯，2025年11月5日，北交所上市公司丹娜生物（920009，收盘价：87.61元）登上龙虎榜，交易方式是连续竞价，披露原因 是当日换手率达到44.61%，成交数量321.22万股，成交金额2.85亿元。买一席位为东方财富证券股份有限公司拉萨团结路第一证 券营业部，买入544.37万元；卖一席位为东方财富证券股份有限公司拉萨团结路第一证券营业部，卖出788.91万元。 每日经济新闻 ...

Market Overview - On November 4, the Shanghai Composite Index fell by 0.41%, with the total margin trading balance at 24,916.23 billion yuan, a decrease of 31.40 billion yuan from the previous trading day [1] - The margin trading balance in the Shanghai market was 12,668.67 billion yuan, down by 4.84 billion yuan; in the Shenzhen market, it was 12,167.81 billion yuan, down by 26.47 billion yuan; and in the Beijing Stock Exchange, it was 79.75 billion yuan, down by 862.47 thousand yuan [1] Industry Performance - Among the industries tracked by Shenwan, 18 sectors saw an increase in margin balances, with the computer industry leading with an increase of 3.92 billion yuan, followed by basic chemicals and food & beverage sectors with increases of 3.40 billion yuan and 3.07 billion yuan, respectively [1] Individual Stock Performance - A total of 1,793 stocks experienced an increase in margin balances, accounting for 47.94% of the total, with 262 stocks seeing an increase of over 5% [1] - The stock with the largest increase in margin balance was Danna Biological, with a latest margin balance of 15.96 million yuan, reflecting a 386.84% increase, although its stock price fell by 16.75% on the same day [1] - Other notable stocks with significant margin balance increases included Weigao Blood Products (603014) and Everbright Jiabao (600622), with increases of 112.18% and 61.73%, respectively [1] Top Margin Balance Increases - The top 20 stocks by margin balance increase averaged a rise of 1.22%, with the highest performers being Jingquanhua (002885), Weigao Blood Products, and Hailu Heavy Industry (002255), which rose by 10.02%, 10.00%, and 9.98%, respectively [2] - Conversely, Danna Biological, Baicheng Pharmaceutical (301096), and Boying Special Welding (301468) saw declines of 16.75%, 10.78%, and 6.52%, respectively [2] Notable Margin Balance Decreases - Among the stocks with significant margin balance decreases, Ruixing Co. (920717) had the largest drop, with a margin balance of 1.11 million yuan, down by 60.33% [4] - Other stocks with notable decreases included Wangcheng Technology and Luqiao Information, with declines of 38.43% and 26.47%, respectively [4]

丹娜生物11月4日交易公开信息 丹娜生物（920009）今日下跌16.75%，全天换手率61.26%，成交额3.95亿元，振幅13.62%。龙虎榜数据 显示，营业部席位合计净卖出975.23万元。 北交所公开信息显示，当日该股因日换手率达61.26%上榜，营业部席位合计净卖出975.23万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交7575.65万元，其中，买入成交额为 3300.21万元，卖出成交额为4275.44万元，合计净卖出975.23万元。 具体来看，今日上榜营业部中，第一大买入营业部为招商证券股份有限公司北京金融大街证券营业部， 买入金额为1085.22万元，第一大卖出营业部为广发证券股份有限公司深圳东滨路营业部，卖出金额为 906.46万元。（数据宝） | 买/ 卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 招商证券股份有限公司北京金融大街证券营业部 | 1085.22 | 0.89 | | 买二 | 东方财富证券股份有限公司拉萨团结路第二证券营业 部 | 682.25 | 404.02 ...

每日经济新闻 （记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。 每经讯，2025年11月4日，北交所上市公司丹娜生物（920009，收盘价：85元）登上龙虎榜，交易方式是连续竞价，披露原因是 当日换手率达到61.26%，成交数量441.05万股，成交金额3.95亿元。买一席位为招商证券股份有限公司北京金融大街证券营业 部，买入1085.22万元；卖一席位为广发证券股份有限公司深圳东滨路营业部，卖出906.46万元。 | | 2025-11-04丹娜生物(920009) 龙虎榜 | | | | --- | --- | --- | --- | | 序号 | 交易营业部名称 | 买入金额(元) | 卖出金额(元) | | ポリ | 招商证券股份有限公司北京金融大街证券营业部 | 10852176.82 | 8900 | | 买2 | 东方财富证券股份有限公司拉萨团结路第二证券营业部 | 6822517.69 | 4040214.6 | | 买3 | 东方财富证券股份有限公司拉萨团结路第一 证券营业部 | 5682419.68 | 4559119.63 | | 买4 ...

Core Insights - The medical device sector experienced a decline of 1.36% on November 4, with Danaher Biomedical leading the drop [1][2] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] Medical Device Sector Performance - Notable gainers included: - Weigao Blood Purification (603014) with a closing price of 46.53, up 10.00% and a trading volume of 157,800 shares, totaling 727 million yuan [1] - Micron Technology (300341) closed at 18.88, up 7.27% with a trading volume of 282,100 shares, totaling 521 million yuan [1] - ZhenDe Medical (603301) closed at 94.69, up 5.60% with a trading volume of 233,600 shares, totaling 2.158 billion yuan [1] - Major decliners included: - Danaher Biomedical (60000ZG6) closed at 85.00, down 16.75% with a trading volume of 44,100 shares [2] - Hotgen Biotech (688068) closed at 140.65, down 10.24% with a trading volume of 51,900 shares, totaling 753 million yuan [2] - Tianzhihang (688277) closed at 17.42, down 6.60% with a trading volume of 139,000 shares [2] Capital Flow Analysis - The medical device sector saw a net outflow of 792 million yuan from institutional investors, while retail investors contributed a net inflow of 401 million yuan [2][3] - Key stocks with significant capital flow include: - Weigao Blood Purification (603014) had a net inflow of 111.4 million yuan from institutional investors, but a net outflow of 82.5 million yuan from retail investors [3] - Micron Technology (300341) experienced a net inflow of 55.9 million yuan from institutional investors, with a net outflow of 19.0 million yuan from retail investors [3] - ZhenDe Medical (603301) had a net inflow of 33.2 million yuan from institutional investors, but a net outflow of 53.4 million yuan from retail investors [3]

| 代码 | 简称 | 上市日期 | 上市首日涨跌 | 上市首日融资余额 | 占流通市值比 | 上市首日融券余额 | | --- | --- | --- | --- | --- | --- | --- | | | | | （%） | （万元） | 例（%） | （万元） | | 920009 | 丹娜生 | 2025.11.03 | 497.08 | 327.80 | 0.45 | 0.00 | | | 物 | | | | | | | 688765 | 禾元生 物-U | 2025.10.28 | 213.49 | 26914.87 | 7.21 | 0.00 | | 688783 | 西安奕 材-U | 2025.10.28 | 198.72 | 25070.06 | 5.91 | 0.00 | | 920020 | 泰凯英 | 2025.10.28 | 188.53 | 1050.08 | 1.22 | 0.00 | | 688759 | 必贝特 U | 2025.10.28 | 74.41 | 6090.80 | 4.23 | 0.00 | | 603175 | 超颖电 | 2025.10.24 | 3 ...

Summary of Key Points Core Viewpoint - On November 3, the total trading volume of individual stocks on the Beijing Stock Exchange reached 1.054 billion shares, with a total transaction value of 26.031 billion yuan, representing a decrease of 6.957 billion yuan compared to the previous trading day. A total of 100 stocks closed higher, while 172 stocks closed lower [1]. Trading Performance - The stock that saw the highest increase was Danah Biotechnology, which surged by 497.08%, with a trading volume of 94.25% and a transaction value of 66.504 million yuan. Other notable gainers included Deer Chemical and Rongyi Precision, which rose by 20.75% and 10.23%, respectively [2][3]. - In terms of trading activity, 74 stocks had transaction values exceeding 10 million yuan, with Fujida, Better Ray, and Danah Biotechnology leading at 983.31 million yuan, 798.4 million yuan, and 665.04 million yuan, respectively [2]. - The overall trading activity showed that 27 stocks had a turnover rate exceeding 10%, with 6 stocks exceeding 20%. The majority of stocks had turnover rates between 1% and 5% [2]. Market Trends - The market experienced a significant decline in transaction value, with a total decrease of 6.957 billion yuan compared to the previous day. This indicates a potential shift in investor sentiment or market conditions [1]. - The performance of individual stocks varied widely, with a notable disparity between gainers and losers, reflecting a mixed market sentiment [1][2].

New Stock Issuance - New stock for Beikang Testing (920160) issued at a price of 6.70 on November 3, 2025[1] - New stock for Danna Biology (920009) issued at a price of 17.10 on November 3, 2025[1] Market Alerts - ST Zhongdi (000609) announced significant abnormal fluctuations on October 30, 2025[1] - Jiangbolong (301308) reported severe abnormal fluctuations on October 30, 2025[1] - Xiangnan Chip (300475) disclosed abnormal fluctuations on October 24, 2025[1] - Shangtai Technology (001301) announced abnormal fluctuations on November 3, 2025[1] - Hainan Development (002163) reported abnormal fluctuations on November 3, 2025[1] - Zhongrui Co., Ltd. (002374) disclosed abnormal fluctuations on November 3, 2025[1] - Fujian Jinsen (002679) announced abnormal fluctuations on November 3, 2025[1] - Yongxing Materials (002756) reported abnormal fluctuations on November 3, 2025[1] - Xinhongze (002836) disclosed abnormal fluctuations on November 3, 2025[1] - Guocheng Mining (000688) announced abnormal fluctuations on November 3, 2025[1]

北交所新股N丹娜（920009）今日上市，开盘上涨447.95%，截至收盘涨幅扩大至497.08%，全天成交量 678.62万股，成交额6.65亿元，换手率94.25%。 证券时报·数据宝统计显示，公司主营业务为侵袭性真菌病血清学早期诊断及其它病原微生物体外诊断 产品的研发、生产和销售。 北交所近期上市新股首日涨跌幅 | 代码 | 简称 | 发行价（元） | 上市日期 | 首日收盘价（元） | 首日涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 920009 | N丹娜 | 17.10 | 2025.11.03 | 102.10 | 497.08 | | 920020 | 泰凯英 | 7.50 | 2025.10.28 | 21.64 | 188.53 | | 920158 | 长江能科 | 5.33 | 2025.10.16 | 18.87 | 254.03 | | 920080 | 奥美森 | 8.25 | 2025.10.10 | 37.11 | 349.82 | | 920015 | 锦华新材 | 18.15 | 2025.09.25 | 42.29 ...